[go: up one dir, main page]

DE19944695A1 - Verfahren zur Verstärkung der Antitumor-Aktivität von Rohdrogen, Zusammensetzung enthaltend eine Rohdroge mit verstärkter Antitumor-Aktivität, Verfahren zur Feststellung der Antitumor-Wirksamkeit aufgrund der Behandlung von Rohdrogen und Verfahren zur Ermittlung der Antitumor-Wirksamkeit von Rohdrogen - Google Patents

Verfahren zur Verstärkung der Antitumor-Aktivität von Rohdrogen, Zusammensetzung enthaltend eine Rohdroge mit verstärkter Antitumor-Aktivität, Verfahren zur Feststellung der Antitumor-Wirksamkeit aufgrund der Behandlung von Rohdrogen und Verfahren zur Ermittlung der Antitumor-Wirksamkeit von Rohdrogen

Info

Publication number
DE19944695A1
DE19944695A1 DE19944695A DE19944695A DE19944695A1 DE 19944695 A1 DE19944695 A1 DE 19944695A1 DE 19944695 A DE19944695 A DE 19944695A DE 19944695 A DE19944695 A DE 19944695A DE 19944695 A1 DE19944695 A1 DE 19944695A1
Authority
DE
Germany
Prior art keywords
mushroom
fungus
raw drug
raw
shiitake
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19944695A
Other languages
German (de)
English (en)
Inventor
Kozo Niwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE19944695A1 publication Critical patent/DE19944695A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE19944695A 1998-09-17 1999-09-17 Verfahren zur Verstärkung der Antitumor-Aktivität von Rohdrogen, Zusammensetzung enthaltend eine Rohdroge mit verstärkter Antitumor-Aktivität, Verfahren zur Feststellung der Antitumor-Wirksamkeit aufgrund der Behandlung von Rohdrogen und Verfahren zur Ermittlung der Antitumor-Wirksamkeit von Rohdrogen Withdrawn DE19944695A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (ja) 1998-09-17 1998-11-13 生薬の抗腫瘍活性強化方法、抗腫瘍活性強化生薬含有組成物、生薬処理の抗腫瘍有効性評価方法、および生薬の抗腫瘍有効性評価方法

Publications (1)

Publication Number Publication Date
DE19944695A1 true DE19944695A1 (de) 2000-03-30

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19944695A Withdrawn DE19944695A1 (de) 1998-09-17 1999-09-17 Verfahren zur Verstärkung der Antitumor-Aktivität von Rohdrogen, Zusammensetzung enthaltend eine Rohdroge mit verstärkter Antitumor-Aktivität, Verfahren zur Feststellung der Antitumor-Wirksamkeit aufgrund der Behandlung von Rohdrogen und Verfahren zur Ermittlung der Antitumor-Wirksamkeit von Rohdrogen

Country Status (19)

Country Link
JP (1) JP2000159682A (it)
KR (1) KR20000023206A (it)
CN (1) CN1255376A (it)
AU (1) AU4486299A (it)
BE (1) BE1012725A5 (it)
CA (1) CA2282234A1 (it)
DE (1) DE19944695A1 (it)
DK (1) DK199901235A (it)
ES (1) ES2155802B1 (it)
FR (2) FR2783426A1 (it)
GB (2) GB9920710D0 (it)
ID (1) ID23150A (it)
IL (1) IL131722A0 (it)
IS (1) IS5183A (it)
IT (1) IT1307267B1 (it)
NL (2) NL1013049C2 (it)
NO (1) NO994463L (it)
SE (2) SE9903307L (it)
SG (1) SG76631A1 (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389466A4 (en) * 2001-04-27 2004-09-22 Ajinomoto Kk Immunopotentiators
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
US7977379B2 (en) 2002-05-15 2011-07-12 Bhn Co., Ltd. Method for angiogenesis inhibition or immunostimulation
JP4681801B2 (ja) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 血管新生阻害剤およびその製造方法
JP2005089417A (ja) * 2003-09-19 2005-04-07 Noevir Co Ltd 糖尿病予防・治療用組成物
JP4587441B2 (ja) * 2004-02-12 2010-11-24 株式会社クレハ 新規な糖尿病治療剤および食品
US8034386B2 (en) 2004-09-17 2011-10-11 Ssi Co., Ltd. Extract from Agaricus blazei Murill capable of suppressing breast cancer
JP2006273835A (ja) * 2005-03-04 2006-10-12 Michishi Tani 悪性腫瘍治療剤及びそれを含む飲食品
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
JPWO2011081024A1 (ja) * 2009-12-29 2013-05-09 株式会社富士見養蜂園 旨味食品及びその製造方法
CN106309511A (zh) * 2016-08-30 2017-01-11 青海民族大学 圆孢蘑菇抑制cdc25酶有效部位及制法和应用
CN106333969A (zh) * 2016-08-30 2017-01-18 青海民族大学 圆孢蘑菇抑制hdac1酶有效部位及制法和应用
WO2019104579A1 (en) * 2017-11-30 2019-06-06 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (ko) * 2020-12-16 2024-03-12 대한민국 잎새버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102602787B1 (ko) * 2020-12-16 2023-11-17 대한민국 꽃송이버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102584680B1 (ko) * 2020-12-17 2023-10-06 대한민국 생리활성 및 영양성분이 증가된 표고버섯차 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (ja) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍機能を有する食品及びその製造法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389466A4 (en) * 2001-04-27 2004-09-22 Ajinomoto Kk Immunopotentiators
CN100391439C (zh) * 2001-04-27 2008-06-04 味之素株式会社 免疫增强剂
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES

Also Published As

Publication number Publication date
CA2282234A1 (en) 2000-03-17
NO994463L (no) 2000-03-20
IS5183A (is) 2000-03-17
SE0100195D0 (sv) 2001-01-24
ES2155802A1 (es) 2001-05-16
ID23150A (id) 2000-03-23
GB2341800A (en) 2000-03-29
NL1013049C2 (nl) 2002-01-11
FR2788697A1 (fr) 2000-07-28
SE9903307D0 (sv) 1999-09-16
CN1255376A (zh) 2000-06-07
GB9920710D0 (en) 1999-11-03
BE1012725A5 (fr) 2001-02-06
SG76631A1 (en) 2000-11-21
AU4486299A (en) 2000-03-30
NL1019705A1 (nl) 2002-01-29
GB9921387D0 (en) 1999-11-10
NL1013049A1 (nl) 2000-03-21
JP2000159682A (ja) 2000-06-13
KR20000023206A (ko) 2000-04-25
ITTO990784A1 (it) 2001-03-14
NO994463D0 (no) 1999-09-15
IT1307267B1 (it) 2001-10-30
SE9903307L (sv) 2000-03-18
NL1019705C2 (nl) 2002-03-26
IL131722A0 (en) 2001-03-19
ITTO990784A0 (it) 1999-09-14
FR2783426A1 (fr) 2000-03-24
DK199901235A (da) 2000-03-18
SE0100195L (sv) 2001-01-24
ES2155802B1 (es) 2001-12-01

Similar Documents

Publication Publication Date Title
AT401346B (de) Verfahren zur herstellung eines antioxidationsmittels, insbesondere zur verwendung als arzneimittel
DE19944695A1 (de) Verfahren zur Verstärkung der Antitumor-Aktivität von Rohdrogen, Zusammensetzung enthaltend eine Rohdroge mit verstärkter Antitumor-Aktivität, Verfahren zur Feststellung der Antitumor-Wirksamkeit aufgrund der Behandlung von Rohdrogen und Verfahren zur Ermittlung der Antitumor-Wirksamkeit von Rohdrogen
DE60218299T2 (de) Eine Dispersion aus Beta-Glukan enthaltenden hochfeinen Partikel, ein entsprechender Herstellungsprozess und die Verwendung der Dispersion
DE69735814T2 (de) Verwendung von komplexen in die herstellung von präparaten zur behandlung empfindlicher haut, verfahren zur herstellung und hypoallergenische präparate
DE60030568T2 (de) Withania somnifera zusammensetzung
DE3784695T2 (de) Gebrauch von Gramineenextrakten als Arzneimittel.
DE60027481T2 (de) Zusammensetzung zur Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben
DE60304447T2 (de) Pflanzliche Zusammensetzung mit Angelica gigantis, Cnidium officinale und Paeonia japonica
DE4320526C2 (de) Ölpräparat und Verfahren zur Herstellung desselben
DE19781489C2 (de) Verfahren zur Verarbeitung von Ginseng und mittels dieses Verfahrens erhaltener verarbeiteter Ginseng
DE4226866A1 (de) Pflanzliche zusammensetzung mit niedrigem molekulargewicht
DE10101543A1 (de) Verfahren zur Erhöhung der Antitumoraktivität einer Amygdalin enthaltenden Substanz, Zusammensetzung mit einem Gehalt an einer Substanz mit erhöhtem Amygdalingehalt, Verfahren zur Bestimmung der Antitumor-Behandlungswirksamkeit einer Amygadlin enthaltenden Substanz und Verfahren zur Bestimmung einer Amygdalin enthaltenden Antitumorsubstanz
EP1945239B1 (de) Zubereitung und anwendung eines phytotherapeutikums
KR101533195B1 (ko) 천연방부제를 사용한 안전한 물티슈 조성물
DE102016125955A1 (de) Polysaccharid zur Anpassung der Immunität, Alterungshemmung und zur Verbesserung der Gehirnaktivität
KR102764355B1 (ko) 수소 및 천연 보존 성분을 함유한 화장품과 그 제조방법
EP1565197B1 (de) Die verwendung von papaya-mus zur behandlung von verdauungsstörungen
CN112274462B (zh) 具有抑菌和表皮保湿作用的复合抑菌剂及其制备和应用
DE60102142T2 (de) Kosmetische verwendung von hopfen und ornithin
KR101850421B1 (ko) 항산화 효과가 증진된 산삼배양근추출물의 발효물을 포함하는 나노에멀젼 및 이를 함유하는 스킨 케어용 화장료 조성물
WO2012022466A1 (de) Zweiphasenpräparat sowie dessen verwendung zur behandlung von herpes
LU500687B1 (de) Nahrungs- oder diätische zusammensetzung
DE69420301T2 (de) Antigeschwürmittel
CN108354879A (zh) 一种祛痘防感染的面霜及其制备方法
DE202023103890U1 (de) Extrakt aus Amlafrüchten und selbigen beinhaltende Nährstoffzusammensetzung

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee